Smith AG - Search Results

1

Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma.

Lightfoot TJ, Skibola CF, Smith AG, Forrest MS, Adamson PJ, Morgan GJ, Bracci PM, Roman E, Smith MT, Holly EA. Lightfoot TJ, et al. Among authors: smith mt, smith ag. Haematologica. 2006 Sep;91(9):1222-7. Haematologica. 2006. PMID: 16956821

2

The importance of full participation: lessons from a national case-control study.

Law GR, Smith AG, Roman E; United Kingdom Childhood Cancer Study Investigators. Law GR, et al. Among authors: smith ag. Br J Cancer. 2002 Feb 1;86(3):350-5. doi: 10.1038/sj.bjc.6600092. Br J Cancer. 2002. PMID: 11875698 Free PMC article.

3

Poor metabolizer status at the cytochrome P450 2C9 and 2D6 loci does not modulate susceptibility to therapy-related acute myeloid leukaemia.

Roddam PL, Allan JM, Rollinson S, Smith AG, Willett EV, Swirsky D, Roman E, Morgan GJ. Roddam PL, et al. Among authors: smith ag. Br J Haematol. 2003 Apr;121(1):192-4. doi: 10.1046/j.1365-2141.2003.04245_3.x. Br J Haematol. 2003. PMID: 12670355 Free article. No abstract available.

4

Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.

Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL, Skibola CF, Smith MT, Morgan GJ. Sibley K, et al. Among authors: smith mt, smith ag. Cancer Res. 2003 Aug 1;63(15):4327-30. Cancer Res. 2003. PMID: 12907599

5

An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents.

Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP, Holowaty EJ, Kohler BA, Wiklund T, Pukkala E, Roman E, Morgan GJ, Allan JM. Worrillow LJ, et al. Among authors: smith aj, smith ag. Clin Cancer Res. 2003 Aug 1;9(8):3012-20. Clin Cancer Res. 2003. PMID: 12912950

6

Representativeness of samples from general practice lists in epidemiological studies: case-control study.

Smith AG, Fear NT, Law GR, Roman E. Smith AG, et al. BMJ. 2004 Apr 17;328(7445):932. doi: 10.1136/bmj.38029.672662.AE. Epub 2004 Feb 27. BMJ. 2004. PMID: 14990513 Free PMC article. No abstract available.

7

High-throughput association testing on DNA pools to identify genetic variants that confer susceptibility to acute myeloid leukemia.

Rollinson S, Allan JM, Law GR, Roddam PL, Smith MT, Skibola C, Smith AG, Forrest MS, Sibley K, Higuchi R, Germer S, Morgan GJ. Rollinson S, et al. Among authors: smith mt, smith ag. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):795-800. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159312

8

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, Swirsky DM, Morgan GJ, Wild CP. Allan JM, et al. Among authors: smith ag. Blood. 2004 Dec 15;104(13):3872-7. doi: 10.1182/blood-2004-06-2161. Epub 2004 Aug 31. Blood. 2004. PMID: 15339847 Free article.

9

Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma.

Willett EV, Smith AG, Dovey GJ, Morgan GJ, Parker J, Roman E. Willett EV, et al. Among authors: smith ag. Cancer Causes Control. 2004 Oct;15(8):771-80. doi: 10.1023/B:CACO.0000043427.77739.60. Cancer Causes Control. 2004. PMID: 15456990

10

Lymphoma: variations in time to diagnosis and treatment.

Howell DA, Smith AG, Roman E. Howell DA, et al. Among authors: smith ag. Eur J Cancer Care (Engl). 2006 Jul;15(3):272-8. doi: 10.1111/j.1365-2354.2006.00651.x. Eur J Cancer Care (Engl). 2006. PMID: 16882124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,102 results

Search Page

Filters